Understanding the Benefits of Enasidenib 50 mg for AML Treatment in India - Delhi
Friday, 29 March 2024
Item details
City:
Delhi
Offer type:
Offer
Item description
Enasidenib represents a significant milestone in the realm of cancer therapy, offering new possibilities for patients with relapsed or refractory AML. Clinical trials have demonstrated the remarkable efficacy of this tablet in the treatment of relapsed or refractory AML with an IDH2 mutation. It operates on a more precise level, targeting specific mutations in cancer cells.Patients receiving it experienced higher rates of complete remission compared to conventional chemotherapy, with some achieving durable responses. With the approval of Enasidenib 50/100 mg in India by regulatory authorities, including the Drug Controller General of India (DCGI), patients now have access to this cutting-edge treatment option. Impomed Healthcare provides this as a valuable treatment option to their patients to fight against leukemia.
Related ads
Impomed, the top supplier of innovative cancer therapies, invites you to explore the healthcare…
Buy #Erlonat 150mg tablets, which come under the generic brand name #Tarceva, and it is used for…
The Geekbar Pro 50mg by GeekVape is a disposable vape device pre-filled with 20mg or 10mg nicotine…
Discover cutting-edge cancer treatment at Impomed Healthcare with our leading approach to…
Cobimetinib is classified as an MEK inhibitor, which means it works by blocking a protein called…
Jpdol tramadol 100mg is a well-known pain reliever. The accurate mechanism of Tramadol is not…
Venetoclax, a novel oral medication, represents a paradigm shift in cancer therapy, particularly in…
Ponatinib 15/30 mg stands at the forefront of revolutionizing cancer treatment in India's oncology…
Sotorasib tablet also known by its brand name Lumakras, is a precision medicine specifically…
In the pursuit of ageless beauty, Derma Puritys proudly unveils a game-changer in skincare – Opus…
